Report Code: A03147 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Clostridium is a gram-positive bacteria and is present in multiple species. This bacteria causes Clostridium difficile infection (CDI), a gastrointestinal illness, which further results in antibiotic-associated diarrhea. This infection is diagnosed by various imaging techniques, such as radiography, CT, and endoscopy.
The major factors that contribute to the growth of the clostridium diagnostics market include the increasing prevalence of clostridium-related diseases, initiatives taken by the government such as awareness programs to educate individuals, adoption of portable POCT products, and technological advancements in immunoassays tests. However, factors such as high costs and less awareness about the test may restrain the market growth.
The development of technologically advanced tests and growing awareness about presymptomatic blood screening for infectious diseases will further provide lucrative market growth opportunities during the forecast period.
The clostridium diagnostics market is segmented on the basis of technology, type, end user, and region. Based on technology, the market is bifurcated into immunoassays and molecular diagnostics. On the basis of product, the market is segmented into clostridium difficile, clostridium perfringens, clostridium botulinum, clostridium tetani, and clostridium sordellii. According to end user, the market is divided into hospitals, government diagnostic laboratories, and independent laboratories. Geographically, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players that operate in this market include Abbott Laboratories, F. Hoffmann-La Roche AG, Siemens AG, Becton, Dickinson and Company, Beckman Coulter, Inc., Sysmex India Pvt. Ltd., Thermo Fisher Scientific Inc., Fujirebio US, Inc., bioMrieux SA, and Diazyme Laboratories, Inc.
Key Benefits
Clostridium Diagnostics Market Report Highlights
Aspects | Details |
---|---|
By Technology |
|
By Product |
|
By End User |
|
By Region |
|
Key Market Players | Sysmex India Pvt. Ltd., Fujirebio US, Inc., Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Abbott Laboratories, Diazyme Laboratories, Inc., Siemens AG, bioMrieux SA, F. Hoffmann-La Roche AG, Beckman Coulter, Inc. |
Loading Table Of Content...
Start reading.
This Report and over 71,229+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers